Mark Denzine, DO
Adult Reconstructive Orthopaedic Surgery · Cleveland, OHNPI 1487670634
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 96.2% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $9,281, more than ten times the $480 reported in 2019.
Across 64 payments — averaging $491.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$30K
- Stryker$369
- Zimmer Biomet$319
- Johnson & Johnson$300
- Radius Health, Inc.$55
- Amgen$52
- plus $93 from 3 others
What the payments were for
- Consulting fees$11,87838%
- Speaking & faculty fees$14,56346%
- Travel & lodging$2,6308%
- Food & beverage$2,3768%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 36 | $30,258 |
| Stryker | 4 | $369 |
| Zimmer Biomet | 3 | $319 |
| Johnson & Johnson(2 entities) | 10 | $300 |
| Radius Health, Inc. | 3 | $55 |
| Amgen | 3 | $52 |
| Pacira Therapeutics, Inc. | 2 | $42 |
| Supreme Orthopedic Systems, LLC | 2 | $32 |
| Boston Scientific | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$24,225
- REAL INTELLIGENCE$23,590
- CORI$6,065
- Journey II BCS$5,300
- Journey II CR$5,300
- JOURNEY II UK$5,300
- Tandem$4,800
- POLARSTEM$4,800
- ACCOLADE$149
- MAKO$148
- Legion$147
- Navio Surgical System$147
- PICO 7 Single Use Negative Pressure Wound Therapy$147
- REGENESORB$147
- ROSA$130
- Legion Revision$108
- Persona$108
How this compares
$31,446 in reported general payments places this provider in the 65th percentile of 59 adult reconstructive orthopaedic surgery providers in Ohio.
See all adult reconstructive orthopaedic surgery providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 191 | $3,131 |
| Meloxicam | 53 | $537 |
| Mupirocin | 17 | $122 |
| Tramadol Hcl | 11 | $38 |
| Amoxicillin | 14 | $12 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Cleveland
- Viktor KrebsCleveland$7.5M
- Nicolas PiuzziCleveland$1.2M
- Michael BloomfieldCleveland$321K
- Trevor MurrayCleveland$192K
- James VoosCleveland$166K
- Peter SuraceCleveland$146K
- Kim StearnsCleveland$80K
- John McLaughlinCleveland$79K
- Michael KolczunCleveland$22K
- Michael ErossyCleveland$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.